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The carotid body (CB) is a key chemoreceptor organ in which glomus cells sense changes
in blood O2, CO2, and pH levels. CB glomus cells have also been found to detect
hypoglycemia in both non-primate mammals and humans. O2 and low-glucose responses
share a common final pathway involving membrane depolarization, extracellular calcium
influx, increase in cytosolic calcium concentration, and neurotransmitter secretion, which
stimulates afferent sensory fibers to evoke sympathoadrenal activation. On the other
hand, hypoxia and low glucose induce separate signal transduction pathways. Unlike O2
sensing, the response of the CB to low glucose is not altered by rotenone, with the low
glucose-activated background cationic current unaffected by hypoxia. Responses of the
CB to hypoglycemia and hypoxia can be potentiated by each other. The counter-regulatory
response to hypoglycemia by the CB is essential for the brain, an organ that is particularly
sensitive to low glucose. CB glucose sensing could be altered in diabetic patients,
particularly those under insulin treatment, as well as in other medical conditions such as
sleep apnea or obstructive pulmonary diseases, where chronic hypoxemia presents with
plastic modifications in CB structure and function. The current review will focus on the
following main aspects: (1) the CB as a low glucose sensor in both in vitro and in vivo
models; (2) molecular and ionic mechanisms of low glucose sensing by glomus cells, (3)
the interplay between low glucose and O2 sensing in CB, and (4) the role of CB low
glucose sensing in the pathophysiology of cardiorespiratory and metabolic diseases, and
how this may serve as a potential therapeutic target.
Keywords: carotid body, glucose sensing, O2 sensing, hypoglycemia, intermittent hypoxia, sleep apnea,
chronic hypoxia, diabetes
INTRODUCTION
Hypoglycemia, or a low blood glucose level, is a physiological
condition that is detected by the body to trigger compensatory
counter-regulatory responses, which are essential for maintaining
glucose supply to organs, such as the brain, strictly dependent on
this metabolite for survival. Alterations of glucose sensing might
play an important pathogenic role in several diseases, especially
those related to sympathoexcitation. The carotid body (CB) is a
key chemoreceptor organ that may critically participate in glucose
homeostasis. The first study linking the CB to glucose metabolism
was reported more than 25 years ago (Alvarez-Buylla and de
Alvarez-Buylla, 1988), and knowledge of the molecular mecha-
nism underlying CB glucose sensing has advanced recently due
in part to improvements in CB preparations that are suitable for
in vitro recording of physiological parameters (Pardal and Lopez-
Barneo, 2002a). The role of the CB in several cardiorespiratory
and metabolic disorders has also been studied in the past few
years (Paton et al., 2013; Ribeiro et al., 2013; Schultz et al., 2013)
with the CB recently proposed as a potential therapeutic target for
these diseases (McBryde et al., 2013).
CAROTID BODY AND O2 SENSING
The CB, the main arterial chemoreceptor, is located at the carotid
artery bifurcation. The CB is composed of clusters (glomeruli) of
electrically excitable neuron-like glomus (type I) cells surrounded
by glia-like sustentacular (type II) cells. Type II cells, or a subpop-
ulation of them, have recently been identified as neural stem cells
that contribute to the growth of the organ in conditions of chronic
hypoxemia (Pardal et al., 2007; Platero-Luengo et al., 2014). Type
I glomus cells have secretory vesicles containing dopamine and
other neurotransmitters. CB glomus cells sense changes in the
chemical composition of blood, including O2 tension (PO2), CO2
tension, pH, and other stimuli (reviewed by Lopez-Barneo et al.,
2008; Kumar and Prabhakar, 2012).
A major physiological function of the CB is to sense changes
in blood PO2, as this variable is not detected by central chemore-
ceptors. CB glomus cells behave as O2-sensitive presynaptic-like
elements. During hypoxia, O2-sensitive K+ channels are closed
in the plasma membrane of glomus cells, which triggers mem-
brane depolarization, Ca2+ influx, and neurotransmitter release.
This signal is sent to the brainstem respiratory centers by afferent
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fibers of the carotid-sinus nerve to mediate a compensatory acute
hyperventilatory response in order to increase O2 tension in the
blood (Weir et al., 2005; Lopez-Barneo et al., 2008). Besides the
CB glomus cells, O2-sensitive ion channels have been described
in numerous cell classes, such as chromaffin cells in the adrenal
medulla, neuroepithelial bodies of the lung, pulmonary and sys-
temic vascular smooth muscle, and heart myocytes among others
(see for review Lopez-Barneo et al., 1999, 2001).
CAROTID BODY AND GLUCOSE SENSING
GLUCOSE SENSING IN DIFFERENT ORGANS
The brain is very sensitive to decreased glucose supply from the
blood. Glucose-sensitive neurons have been found in different
regions of the brain (Routh, 2002), including the hypothalamus
(Biggers et al., 1989; Dunn-Meynell et al., 2002; Levin et al., 2004;
Burdakov et al., 2006) and striatum (Calabresi et al., 1997) to
mediate reflexes that counter-balance the changes of glucose level.
Glucose-sensitive neurons have specific functional and molecular
properties. Glut2, a low-affinity glucose transporter is expressed
in some glucose-sensing cells (Schuit et al., 2001; Thorens, 2001).
Glucokinase, a low-affinity hexokinase characteristic of pancre-
atic beta cells, seems to play an important role in both glucose-
stimulated and inhibited neurons (Dunn-Meynell et al., 2002).
In addition to the well-established role of central neurons in glu-
cose control, numerous pieces of evidence indicate that glucose
sensors also exist at the periphery and that they have an essen-
tial physiological role (Cane et al., 1986). In addition to α-cells
of the pancreas, hypoglycemia-sensitive cells have also been sug-
gested to exist in the liver (Hamilton-Wessler et al., 1994), near
the portal vein (Hevener et al., 1997), and in the adrenal gland of
the newborn (Livermore et al., 2012).
CAROTID BODY AS A SENSOR OF LOW GLUCOSE
The first evidence linking the CB with glucose metabolism
was reported by Alvarez-Buylla and de Alvarez-Buylla (1988),
Alvarez-Buylla and Roces de Alvarez-Buylla (1994). More
recently, in vivo studies demonstrated that the counter-regulatory
response to insulin-induced hypoglycemia is impaired in CB-
resected dogs (Koyama et al., 2000). Moreover, these animals
exhibit suppressed exercise-mediated induction of arterial plasma
glucagon and norepinephrine and, therefore, cannot maintain
blood glucose levels during exercise (Koyama et al., 2001).
Direct molecular proof of the CB as a glucose-sensing organ
was first reported by Pardal and López-Barneo using the CB
thin slice preparation and amperometry techniques (Pardal and
Lopez-Barneo, 2002b). In this in vitro system, rat CB glomus
cells secrete neurotransmitter when exposed to a glucose-free
solution (Figures 1A,B) (Garcia-Fernandez et al., 2007). This
secretory activity is reversible, depending on external Ca2+ influx
(Figure 1C), and is proportional to the degree of glucopenia.
Responses to hypoglycemia, including neurotransmitter release
and sensory fiber discharge, have also been observed in other
in vitro studies using rat CB slices (Garcia-Fernandez et al.,
2007; Zhang et al., 2007), rat CB/petrosal ganglion co-culture
(Zhang et al., 2007), and cat CB (Fitzgerald et al., 2009). Recently,
the hypoglycemia-mediated secretory response has also been
detected in human glomus cells dispersed from post mortem
CBs (Ortega-Saenz et al., 2013) (see below). However, this topic
is controversial as other groups have failed to detect glucose
sensing by explanted CBs or dissociated rat CB cells (Bin-Jaliah
et al., 2004; Gallego-Martin et al., 2012). Bin-Jaliah et al. (2004)
reported CB stimulation in rats secondary to insulin-induced
hypoglycemia. However, they proposed that sensing of hypo-
glycemia by the CB could be an indirect phenomenon dependent
on other metabolically mediated blood borne factor. Systemic
studies performed in humans have also reported opposing results
regarding the role of the CB in hormonal counter-regulatory
responses to hypoglycemia (Ward et al., 2009; Wehrwein et al.,
2010). Although not fully understood, these discrepancies could
possibly result from differences in CB sample preparation or lim-
itations in experimental design. In any event, taken together the
available experimental data suggests that low glucose sensing by
CBs is likely to be a general phenomenon among mammals that
has potential pathophysiological implications.
MOLECULAR AND IONIC MECHANISMS OF LOW GLUCOSE SENSING
BY CAROTID BODY GLOMUS CELLS
The molecular mechanisms underlying CB glomus cell activation
by hypoglycemia have been investigated in both lower mammals
and human CB tissue samples (Pardal and Lopez-Barneo, 2002b;
Garcia-Fernandez et al., 2007; Zhang et al., 2007; Fitzgerald et al.,
2009; Ortega-Saenz et al., 2013). In our initial study we reported
that, like O2 sensing by the CB, macroscopic voltage-gated out-
ward K+ currents are inhibited in patch-clamped rat glomus
cells exposed to glucose-free solutions (Pardal and Lopez-Barneo,
2002b). However, we soon realized that besides this phenomenon,
low glucose elicits a membrane depolarization of ∼8mV
(Figures 1D,E) (Garcia-Fernandez et al., 2007), which is the main
process leading to extracellular Ca2+ influx into glomus cells,
as demonstrated by microfluorimetry experiments using Fura-2-
AM labeled cells (Figure 1F) (Pardal and Lopez-Barneo, 2002b;
Garcia-Fernandez et al., 2007; Ortega-Saenz et al., 2013). The
increase in intracellular Ca2+, which is demonstrated by the
inhibition of the secretory activity by Cd2+, a blocker of voltage-
gated Ca2+ channels (Pardal and Lopez-Barneo, 2002b; Garcia-
Fernandez et al., 2007), results in exocytotic neurotransmitter
release (Pardal and Lopez-Barneo, 2002b; Garcia-Fernandez et al.,
2007; Zhang et al., 2007; Ortega-Saenz et al., 2013). This neu-
rotransmitter release triggers afferent discharge and activation
of counter-regulatory autonomic pathways to increase the blood
glucose level (Zhang et al., 2007; Fitzgerald et al., 2009). The
depolarizing receptor potential triggered by low glucose has a
reversal potential above 0mV and is due to the increase of a stand-
ing inward cationic current (carried preferentially by Na+ ions)
present in glomus cells (Figures 1G,H) (Garcia-Fernandez et al.,
2007). Indeed, in contrast with hypoxia, low glucose decreases
the membrane resistance of glomus cells recorded with the perfo-
rated patch configuration of the patch clamp technique to ∼50%
of control (González-Rodríguez and López-Barneo, unpublished
results). As reported by others (Carpenter and Peers, 2001), the
background Na+ current plays a major role in chemotransduc-
tion by glomus cells as it sets the membrane potential to relatively
depolarized levels, near the threshold for the opening of Ca2+
channels.
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FIGURE 1 | Counter-regulatory response to hypoglycemia in rat carotid
body (CB) slices and isolated glomus cells. A representative secretory
response (A) and average secretion rate (B) induced by glucopenia in glomus
cells from CB slices (n = 3). (C) Abolition of the secretory response to
hypoglycemia by 100μM Cd2+. A representative depolarizing receptor
potential (D) and average membrane potential (E) induced by 0 glucose in CB
glomus cells (n = 25). (F) Reversible increase in cytosolic Ca2+ concentration
in a Fura-2-loaded glomus cell in response to 0 glucose. (G) Abolition of 0
glucose-induced increase in current (Icontrol-I0glu) by replacement of
extracellular Na+ with N-methyl-D-glucamine (0 Na+) in voltage-clamped
glomus cells (n = 3). (H) Inhibition of 0 glucose-induced depolarization
(Vcontrol-V0glu) by replacement of extracellular Na+ with
N-methyl-D-glucamine (0 Na+) in current-clamped glomus cells (n = 3). To
compensate for the hyperpolarization induced by 0 Na+, Vm was changed
manually to the previous resting value (arrow) ∗p < 0.05 (Modified from
Garcia-Fernandez et al., 2007).
GLUCOSE TRANSPORT AND METABOLISM IN THE CAROTID BODY
DURING LOW GLUCOSE SENSING
The mechanism of low glucose sensing by CB glomus cells does
not seem to be the same as high glucose sensing by other glucose-
sensing cells in terms of glucose transport and metabolism.
Glut2 and glucokinase, molecules specifically expressed in high
glucose-sensing cells (Schuit et al., 2001; Thorens, 2001), are not
expressed in the CB (Garcia-Fernandez et al., 2007). However,
glucose metabolism appears to be necessary for low glucose sens-
ing by the CB, since non-metabolizable glucose fails to prevent the
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glucose deficiency-induced catecholamine secretion by glomus
cells (Garcia-Fernandez et al., 2007).
REGULATION OF CAROTID BODY LOW GLUCOSE SENSING
SIMILARITIES AND DIFFERENCES BETWEEN LOW GLUCOSE AND O2
SENSING
O2 and low-glucose sensing by the CB share many similari-
ties. Both signaling pathways involve the inhibition of voltage-
gated K+ channels, plasma membrane depolarization, influx of
extracellular Ca2+, neurotransmitter release, and afferent nerve
firing to transmit the signal to the brain, in order to trig-
ger counter-regulatory responses to increase blood O2 tension
and glucose concentration. On the other hand, the initial steps
of the signaling pathways are different for each. Low glucose
triggers a depolarizing receptor potential, which is dependent
on the activation of background cationic Na+-permeable chan-
nels (Garcia-Fernandez et al., 2007), which do not seem to be
regulated by hypoxia (Carpenter and Peers, 2001). Although
voltage-gated K+ channels are inhibited upon exposure of CB
glomus cells to low glucose, this inhibition has a minimal effect
regarding neurotransmitter secretion (Garcia-Fernandez et al.,
2007). Indeed, as stated above, low glucose induces a decrease
in the input resistance of cells, whereas the predominant effect
of hypoxia is an increase in input resistance. Although glomus
cells normally secrete neurotransmitters in response to glucose
and hypoxia, there are cells that respond to only one of these
two stimuli (Figures 2A,B). Moreover, rotenone, a specific mito-
chondrial complex I inhibitor, which blocks hypoxia-induced
catecholamine secretion (Ortega-Saenz et al., 2003), shows no
effect on the low glucose-induced secretory activity in CB cells
(Figures 2C,D) (Garcia-Fernandez et al., 2007). Therefore, it
appears that sensitivities to hypoglycemia and hypoxia depend
on separate signal transduction mechanisms, although they share
the same final steps leading to transmembrane Ca2+ influx
and neurotransmitter release. The mechanism of CB O2 sens-
ing is as yet unknown; however a considerable body of knowl-
edge including our rotenone data, suggests that mitochondria
may play an important direct or indirect role (Ortega-Saenz
FIGURE 2 | Differential sensitivity of glomus cells to oxygen and low
glucose in rat carotid body slices. (A,B) Examples of cells with
differential secretory responses to hypoxia and low glucose. Differential
effect of 100 nM rotenone on the secretory response induced by hypoxia
(C) (n = 14) and hypoglycemia (D) (n = 5), as demonstrated by a
representative amperometric recording, cumulative secretion signal, and
average secretion rate. ∗p < 0.05 (Modified from Garcia-Fernandez et al.,
2007).
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et al., 2003; see Buckler and Turner, 2013 for an update and
references). The fact that rotenone does not alter glomus cell
responses to hypoglycemia indicates that low glucose sensing is
not related to oxidative phosphorylation and could depend on
metabolites of the glycolytic pathway (Garcia-Fernandez et al.,
2007).
INTERPLAY BETWEEN LOW GLUCOSE AND O2 SENSING
The brain is very sensitive to decreases both in arterial O2 tension
and glucose level. Being a polymodal sensor of O2, glucose, pH,
CO2, etc., a coordinated response to hypoxia and hypoglycemia
by CB chemoreceptors could prevent to a major extent the detri-
mental effects caused by both conditions. Although a small per-
centage of CB glomus cells respond specifically to only hypoxia or
low glucose (Garcia-Fernandez et al., 2007), in a majority of glo-
mus cells hypoxia and hypoglycemia can potentiate each other’s
response, such as is seen with neurotransmitter release and affer-
ent discharge (Pardal and Lopez-Barneo, 2002b; Zhang et al.,
2007; Fitzgerald et al., 2009). The secretory response to low glu-
cose increases in the presence of low PO2 in rat CB slices (Pardal
and Lopez-Barneo, 2002b), and we have recently shown that glo-
mus cells in the human CB are also glucose sensors and show
the same responses (cell depolarization, increased cytosolic Ca2+
and neurotransmitter secretion), as described in lower mammals
(Figures 3A–D). In this preparation, hypoxia (6%O2) potentiates
low glucose-induced catecholamine secretion, whereas low glu-
cose further induces Ca2+ influx during hypoxia (Figures 3D,E).
The effect of hyperoxia on hypoglycemia and the effect of hyper-
glycemia on hypoxia are less well known. A recent human study
suggested that hyperoxia could blunt the hypoglycemia effect
(Wehrwein et al., 2010). Another study suggested that both hypo
and hyperglycemia could increase the hypoxic response in human
subjects (Ward et al., 2007).
INTERMITTENT HYPOXIA AND GLUCOSE SENSING
No direct evidence has been reported regarding the effect of
intermittent hypoxia on glucose sensing by the CB. In rat CB glo-
mus cells, intermittent hypoxia enhances acute hypoxia-induced
membrane depolarization and the inhibition of TASK-like K+
channels (Ortiz et al., 2013). Intermittent hypoxia has also been
found to augment the CB sensory response to acute hypoxia
and to enhance the hypoxic ventilatory chemoreflex in neona-
tal rats (Peng et al., 2004). However, a recent study reported
an exaggerated activation of CB afferent activity accompanied
by hypoventilation in a rat model of intermittent hypoxia when
exposed to acute hypoxia (Gonzalez-Martin et al., 2011). It is
logical to speculate that intermittent hypoxia could potentiate
the carotid chemoreceptor response to hypoglycemia, as occurs
with hypoxia. Indeed, intermittent hypoxia has been found to
be associated with altered glucose metabolism in rodent mod-
els. Intermittent hypoxia results in an increase in fasting glu-
cose and a decrease in insulin level in neonatal rats, which
is associated with a disturbed glucose homeostasis (Pae et al.,
2013). In mouse, intermittent hypoxia triggers increased fast-
ing glucose and decreased sensitivity to insulin, with the for-
mer being reversed by discontinuation of exposure to hypoxia
(Polak et al., 2013). Few human studies have been carried
out to study the relationship between intermittent hypoxia
and glucose homeostasis. Individuals exposed to intermittent
hypoxia demonstrate an increased sympathetic nerve activity
(Cutler et al., 2004), while male adults exposed to high alti-
tude hypoxia have decreased insulin sensitivity (Larsen et al.,
1997).
INSULIN AND CAROTID BODY GLUCOSE SENSING
In addition to hypoxia and intermittent hypoxia, insulin was
found recently to be a regulator of the CB response to hypo-
glycemia. Indeed, insulin was proposed as a new intermittent
hypoxia-like agent, and carotid chemoreceptors have been sug-
gested to contribute to insulin-mediated sympathoexcitation
(Limberg et al., 2014). Animal studies indicate that CB cells
have insulin receptors and respond to increases in insulin levels
by inducing sympathetic activation, as demonstrated by altered
arterial blood pressure, breathing, and neurotransmitter release
(Bin-Jaliah et al., 2004; Ribeiro et al., 2013). The combined acti-
vation of CB chemoreceptors by insulin and low glucose may
serve as a counter-balance mechanism to limit the decrease of
glucose levels in insulin-treated patients. In this regard, it would
be interesting to explore whether long-lasting CB exposure to
high glucose, as occurs in diabetic patients, alters the low glucose
sensitivity of glomus cells.
CAROTID BODY DYSFUNCTION IN DISEASE STATES
CB acts as a combined oxygen and glucose sensor to facilitate acti-
vation of the counter-regulatory measures in response to small
reductions of either variable. Such measures include, on one
hand, hyperventilation and increased blood pressure to facilitate
blood-borne O2 supply to organs and, on the other hand liver
glycogenolysis and insulin resistance of peripheral tissues to com-
bat hypoglycemia. Diseases altering the structure and function
of CB chemoreceptors could have detrimental effects, leading to
dysregulation of glucose homeostasis.
OBSTRUCTIVE SLEEP APNEA
Obstructive sleep apnea (OSA) is a common clinical syndrome
characterized by intermittent hypoxia and sleep fragmentation.
OSA is a well-established significant risk factor for cardiovascular
disease and mortality. As indicated above Intermittent Hypoxia
and Glucose Sensing, chronic intermittent hypoxia results in CB
chemoreceptor over-stimulation and augmentation of CB sen-
sory responses in rats (Peng et al., 2003) and humans (Cutler
et al., 2004). Intermittent hypoxia has been found to be asso-
ciated with altered glucose metabolism and insulin resistance
in rodent models (Pae et al., 2013; Polak et al., 2013), but its
effects on glucose homeostasis in humans are as yet unstud-
ied. It can be expected that CB overstimulation and growth seen
in OSA patients (Nair et al., 2013; Abboud and Kumar, 2014)
should lead to hyperglycemia and over-sensitivity to low glucose.
Nevertheless, O2 and glucose act on separate sensing mecha-
nisms in glomus cells and, in addition, OSA can be accompanied
by hypertension and diabetes. Therefore, the impact of OSA
syndrome on CB-mediated glucose homeostasis requires future
studies using human CB tissue samples (Ortega-Saenz et al.,
2013).
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FIGURE 3 | Responses of human carotid body (CB) glomus cells to low
glucose and hypoxia. (A) Depolarizing receptor potential recorded in a
current-clamped human glomus cell in response to glucopenia. (B) Reversible
increase in cytosolic Ca2+ in a Fura-2-loaded glomus cell exposed to 0
glucose. (C) Average secretion rate induced by hypoglycemia (n = 2).
(D) Secretory response to 0 glucose of glomus cells in CB slices and the
potentiation of the 0 glucose-induced secretory response by mild hypoxia
(6% O2) as demonstrated by a representative amperometric recording (top)
and cumulative secretion signal (bottom). (E) Representative recording of a
reversible increase of cytosolic Ca2+ in a Fura-2-loaded glomus cell,
demonstrating the potentiation of the hypoxic-response by hypoglycemia.
Modified from Ortega-Saenz et al. (2013).
DIABETES
Type 2 diabetes is a major chronic disease associated with high
morbidity, mortality, and economic burden. Glucose sensing is
essential for insulin-treated diabetic patients to counter-regulate
insulin-induced hypoglycemia. It has been proposed that the CB
dysfunction, increasing sympathetic tone and catecholamines in
the blood, could possibly contribute to the pathogenesis of type 2
diabetes and essential hypertension (Nimbkar and Lateef, 2005).
Using a computed tomographic angiography technique, enlarge-
ment of the CB is observed in patients with diabetes mellitus,
hypertension, and congestive heart failure relative to controls,
which supports the proposed functional relationship between
Frontiers in Physiology | Integrative Physiology October 2014 | Volume 5 | Article 398 | 6
Gao et al. Carotid body glucose sensing and disease
the CB and sympathetically mediated disease states (Cramer
et al., 2014). In insulin-dependent diabetic rats, the CB vol-
ume is increased, due to an increase in the extravascular volume
(Clarke et al., 1999). It is still unclear whether the CB enlargement
is a cause of diseases or a consequence of disease progression.
Whether CB glucose sensing is altered in diabetic patients is also
unknown (see below).
RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA AND
DIABETES
OSA syndrome and type 2 diabetes are also strongly linked to
each other. Patients with OSA have an increased incidence of
impaired glucose metabolism and are at an increased risk of
developing type 2 diabetes (Tasali et al., 2008). On the other
hand, the majority of patients with type 2 diabetes also have
OSA (Tasali et al., 2008). Although the mechanism is most likely
multifactorial, chronic intermittent hypoxia experienced by OSA
patients could trigger CB chemoreceptor over-activity, leading to
insulin resistance and abnormal glucose metabolism (Tasali et al.,
2008). Indeed, insulin resistance is developed in both lean mice
(Iiyori et al., 2007) and genetically obese mice (Polotsky et al.,
2003) treated with intermittent hypoxia. The secretory activity of
the CB is increased in the insulin-resistant rat model, whereas
carotid sinus nerve resection prevents CB over-activation and
diet-induced insulin resistance (Ribeiro et al., 2013). Therefore,
sympathoexcitation due to CB over-stimulation could play an
important role in the pathogenesis of both OSA and type 2
diabetes.
CONCLUSIONS
Carotid chemoreceptors work in coordination with other glucose
sensing organs to counter-regulate hypoxia and hypoglycemia.
The responses to hypoxia and hypoglycemia could be potentiated
by each other. Failure to respond to these stresses could lead to
malfunction of organs, such as the brain, which is highly sen-
sitive to glucose and O2 levels. Indeed, defects in CB function
have been associated with several respiratory disturbances, par-
ticularly in the newborn (reviewed by Lopez-Barneo et al., 2008).
CB over-stimulation could also exert detrimental effects, as has
been demonstrated in OSA, hypertension and type 2 diabetes.
However, whether the intrinsic glucose responsiveness of glomus
cells is altered in these diseases is yet to be determined. Due to
the essential role of the CB in sympathetic activation, this organ
could serve as a potential therapeutic target for diseases with sus-
tained hyperinsulinemia and sympathoexcitation, such as obesity,
hypertension, sleep apnea, metabolic syndrome, cardiovascular
disease, and diabetes (Paton et al., 2013). Evaluation of CB size
in these conditions can be now studied with noninvasive com-
puted tomography angiography (Nair et al., 2013; Cramer et al.,
2014). However, bilateral surgical ablation of the CB performed in
asthmatic patients or during neck tumor surgery causes perma-
nent abolition of the ventilatory response to hypoxia. In addition,
this condition causes a decrease in the CO2 sensitivity of the
respiratory center and, in some cases, long term resting hypoven-
tilation and hypercapnia (reviewed by Timmers et al., 2003,
see also Dahan et al., 2007). The counter-regulatory response
to hypoglycemia could be also altered in patients who have
had their CB removed, a status particularly critical in diabetic
patients subjected to insulin treatment and therefore at high
risk of hypoglycemia. Unilateral CB resection appears to be well
tolerated (reviewed by Timmers et al., 2003, see also Minguez-
Castellanos et al., 2007), thus making this likely to be a safer
therapeutic option. Ideally, new reversible pharmacological tools
should be developed to inhibit CB function. In this regard, selec-
tive inhibition of the O2-sensing mechanisms or CB growth in
chronic hypoxia (Platero-Luengo et al., 2014) could reduce CB
over-activation while maintaining intact the counter-regulatory
response to low glucose.
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